The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Binosto Once Weekly 70 mg Effervescent Tablets

70 milligram(s) Effervescent tablet

Lexon (UK) LtdPPA1097/045/001

Main Information

Trade NameBinosto Once Weekly 70 mg Effervescent Tablets
Active SubstancesSodium alendronate trihydrate (micronised)
Strength70 milligram(s)
Dosage FormEffervescent tablet
Licence HolderLexon (UK) Ltd
Licence NumberPPA1097/045/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA04 alendronic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued27/04/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0051-101-057
Interchangeable List DocumentPDF of Interchangeable List
« Back